Ambitious Bio maps proteins with $6M seed

Ambitious Bio launched Corpus with $6 million in seed funding; the protein atlas increased detected protein inventory in every one of 181 head-to-head tissue comparisons, with typical gains of 28% to 78%, according to the launch release. The company says the dataset is designed to expose healthy-tissue expression before drug developers commit to trials; teams building biological models should treat richer measurement as an infrastructure input, not assume a larger model can compensate for missing tissue data, as GPT-Rosalind’s drug-discovery thesis also argues.